ArticleCancer2019

Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.

Jessica Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.